"Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial"
about Evelo Biosciences, Inc.
Notified: 02:00 EDT at $3.73
"FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA"
about FSD Pharma Inc.
Notified: 02:31 EDT at $4.00
"Aridis Reports AR-501 Clinical Data: Positive Safety Data in Healthy Subjects of a Phase 1/2a Clinical Trial"
about Aridis Pharmaceuticals In..
Notified: 05:31 EDT at $7.14
"Cinedigm Partners with Team Whistle to Accelerate Distribution of OTT Linear and VOD Network Whistle TV"
about Cinedigm Corp
Notified: 06:00 EDT at $2.31
"G1 Therapeutics and Genor Biopharma Announce Exclusive License Agreement for Lerociclib in Asia-Pacific Region"
about G1 Therapeutics, Inc.
Notified: 06:01 EDT at $24.50
"Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta"
about La Jolla Pharmaceutical C..
Notified: 06:01 EDT at $5.31
"Aurinia Completes Patient Enrollment Into the AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for the Treatment of Dry Ey..."
about Aurinia Pharmaceuticals I..
Notified: 06:05 EDT at $16.72
"SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b Combination Study Evaluating Nirogacestat and GlaxoSmithKline’s Belan..."
about GlaxoSmithKline PLC
Notified: 06:30 EDT at $41.63
"Esperion and Daiichi Sankyo Europe Announce Amendment to License and Commercial Collaboration Agreement"
about Esperion Therapeutics, In..
Notified: 07:00 EDT at $43.72
"Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B"
about Altimmune, Inc.
Notified: 07:01 EDT at $7.96
"Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug C..."
about Sutro Biopharma, Inc.
Notified: 07:02 EDT at $9.26
"HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB‑101"
about HOOKIPA Pharma Inc.
Notified: 07:15 EDT at $11.70
"Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor"
about Revolution Medicines, Inc..
Notified: 07:30 EDT at $37.65
"New Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancers"
about Theratechnologies Inc.
Notified: 07:30 EDT at $1.89
"ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II"
about ESSA Pharma Inc.
Notified: 07:31 EDT at $5.20
"Athenex Announces $225 Million Loan Agreement with Oaktree"
about Athenex, Inc.
Notified: 08:00 EDT at $13.26
"Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarci..."
about Onconova Therapeutics, In..
Notified: 08:00 EDT at $0.61
"Ziopharm Oncology Completes Enrollment of Phase 2 Trial Evaluating Controlled IL-12 in Combination with Libtayo® in Patients with Glioblasto..."
about ZIOPHARM Oncology Inc
Notified: 08:00 EDT at $3.24
"aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Mee..."
about aTyr Pharma, Inc.
Notified: 08:01 EDT at $4.67
"Aqua Metals Successfully Completes Initial Run of First V1.25 Electrolyzer - Two Weeks Ahead of Schedule"
about Aqua Metals, Inc.
Notified: 08:01 EDT at $1.03
"Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines"
about Pfizer, Inc.
Notified: 08:01 EDT at $33.30
"21Vianet Announces US$150 million Investment from Blackstone"
about 21Vianet Group, Inc.
Notified: 08:02 EDT at $18.41
"Fuling Global Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company at $2.18 per Share"
about Fuling Global Inc.
Notified: 08:15 EDT at $1.99
"Allogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia"
about Allogene Therapeutics, In..
Notified: 08:31 EDT at $40.65
"Inpixon to Acquire Exclusive Global License for Development and Distribution of Systat and SigmaPlot Software Suite"
Notified: 08:31 EDT at $1.75
"DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM..."
about DelMar Pharmaceuticals, I..
Notified: 08:31 EDT at $1.15
"Marrone Bio Innovations Regains Compliance with Nasdaq Minimum Bid Price Requirement"
about Marrone Bio Innovations, ..
Notified: 08:31 EDT at $1.05
"Arcutis Enrolls Last Patient in Phase 2 Proof of Concept Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatme..."
about Arcutis Biotherapeutics, ..
Notified: 09:00 EDT at $33.80
"CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Myers Squibb at AA..."
about CytomX Therapeutics, Inc.
Notified: 09:00 EDT at $8.77
"Jounce Therapeutics Presents First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at The American Assoc..."
about Jounce Therapeutics, Inc.
Notified: 09:00 EDT at $6.50
"PureTech Presents New Data Reinforcing Galectin-9 as a Compelling Therapeutic Target and Biomarker for a Range of Cancers at the American As..."
about Galectin Therapeutics Inc..
Notified: 09:01 EDT at $2.88
"Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors"
about Beyond Air, Inc.
Notified: 09:01 EDT at $7.55
"Mersana Therapeutics Presents Preclinical Data from its Innovative Dolasynthen and Immunosynthen ADC Platforms at American Association for C..."
about Mersana Therapeutics, Inc..
Notified: 09:05 EDT at $19.99
"Neoleukin Therapeutics Presents Preclinical Data for NL-201 and De Novo Protein Design Technology at American Association for Cancer Researc..."
about Neoleukin Therapeutics, I..
Notified: 09:05 EDT at $16.50
"Xencor Presents Data from Four Preclinical XmAb® 2+1 Bispecific Antibody and Cytokine Programs at AACR Virtual Annual Meeting II"
about Xencor, Inc.
Notified: 09:07 EDT at $30.77
"Adesto® Announces Completion of CFIUS Review for Proposed Acquisition of Adesto by Dialog Semiconductor"
about Adesto Technologies Corpo..
Notified: 09:15 EDT at $12.40
"Affimed Announces Presentation of Data on Genentech’s RO7297089 and AFM24, Both Innate Cell Engagers Developed from Affimed’s ROCK® Platform..."
about Innate Pharma S.A.
Notified: 09:20 EDT at $6.22
"Agenus Cell Therapy and Checkpoint Antibody Combinations Show Curative Preclinical Efficacy at AACR 2020"
about Agenus Inc.
Notified: 09:44 EDT at $3.88
"Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs"
about Kazia Therapeutics Limite..
Notified: 10:31 EDT at $3.46
"Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymp..."
about Karyopharm Therapeutics I..
Notified: 11:25 EDT at $20.72
"Vizient Announces Novaplus Enhanced Supply Agreement with Pfizer for Six Essential Medications"
about Pfizer, Inc.
Notified: 13:00 EDT at $33.05
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.